Cocrystal and Salt Forms of Furosemide: Solubility and Diffusion Variations

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Crystal Growth & Design

• Publication date

  2016-08-03

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1021/ACS.CGD.6B00902
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmaceutical cocrystals: walking the talk.

  2016cited by this paper
• Pharmaceutical cocrystals: along the path to improved medicines.

  2016cited by this paper
• Hydrogen Bond Synthons in the Interplay of Solubility and Membrane Permeability/Diffusion in Variable Stoichiometry Drug Cocrystals

  2015cited by this paper
• Cocrystals of Hydrochlorothiazide: Solubility and Diffusion/Permeability Enhancements through Drug-Coformer Interactions.

  2015cited by this paper
• Furosemide Cocrystals with Pyridines: An Interesting Case of Color Cocrystal Polymorphism

  2015cited by this paper
• High solubility crystalline hydrates of Na and K furosemide salts

  2014cited by this paper
• Aniline–phenol recognition: from solution through supramolecular synthons to cocrystals

  2014cited by this paper
• Furosemide Solvates: Can They Serve As Precursors to Different Polymorphs of Furosemide?

  2014cited by this paper
• Furosemide Cocrystals: Structures, Hydrogen Bonding, and Implications for Properties

  2014cited by this paper
• Soluble Cocrystals of the Xanthine Oxidase Inhibitor Febuxostat

  2013cited by this paper
• New Solid Forms of the Anti-HIV Drug Etravirine: Salts, Cocrystals, and Solubility

  2013cited by this paper
• Salt and cocrystals of sildenafil with dicarboxylic acids: solubility and pharmacokinetic advantage of the glutarate salt.

  2013cited by this paper
• Biorelevant characterisation of amorphous furosemide salt exhibits conversion to a furosemide hydrate during dissolution.

  2013cited by this paper
• Solubility Advantage of Tenoxicam Phenolic Cocrystals Compared to Salts

  2013cited by this paper
• Polymorphs and a Hydrate of Furosemide–Nicotinamide 1:1 Cocrystal

  2012cited by this paper
• Isonicotinamide self-association: the link between solvent and polymorph nucleation.

  2012cited by this paper
• The Solubility–Permeability Interplay and Its Implications in Formulation Design and Development for Poorly Soluble Drugs

  2012cited by this paper
• Multicomponent pharmaceutical cocrystals: furosemide and pentoxifylline.

  2012cited by this paper
• The solubility-permeability interplay when using cosolvents for solubilization: revising the way we use solubility-enabling formulations.

  2012cited by this paper
• Pharmaceutical cocrystals of ethenzamide: structural, solubility and dissolution studies

  2012cited by this paper
• Novel furosemide cocrystals and selection of high solubility drug forms.

  2012cited by this paper
• Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals

  2011cited by this paper
• Fast Dissolving Curcumin Cocrystals

  2011cited by this paper
• Pharmaceutical Salts and Co-crystals

  2011cited by this paper
• Conformational and Synthon Polymorphism in Furosemide (Lasix)

  2010cited by this paper
• Biowaiver monographs for immediate release solid oral dosage forms: furosemide.

  2010cited by this paper
• Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?

  2009cited by this paper
• Solubility Advantage of Pharmaceutical Cocrystals

  2009cited by this paper
• Understanding and Predicting the Effect of Cocrystal Components and pH on Cocrystal Solubility

  2009cited by this paper
• A short history of SHELX.

  2008cited by this paper
• Effect of pH on the solubility and release of furosemide from polyamidoamine (PAMAM) dendrimer complexes.

  2007cited by this paper
• Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations.

  2007cited by this paper
• Encyclopedia of Heart Diseases

  2006cited by this paper
• Alterations in intestinal permeability

  2006cited by this paper
• Comparison of a miniaturized shake-flask solubility method with automated potentiometric acid/base titrations and calculated solubilities.

  2005cited by this paper
• Linking solution chemistry to crystal nucleation: the case of tetrolic acid.

  2005cited by this paper
• Crystallization of a salt of a weak organic acid and base: solubility relations, supersaturation control and polymorphic behavior.

  2005cited by this paper
• Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system.

  2004cited by this paper
• Absorption and Drug Development: Solubility, Permeability, and Charge State

  2003cited by this paper
• Physicochemical Profiling (Solubility, Permeability and Charge State)

  2001cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

  2001cited by this paper
• WinGX suite for small-molecule single-crystal crystallography

  1999cited by this paper
• Supramolecular Synthons in Crystal Engineering—A New Organic Synthesis

  1995cited by this paper
• Journal of

  1993cited by this paper
• Physicochemical Properties of Nitrofuratoin Anhydrate and Monohydrate and Their Dissolution

  1991cited by this paper
• Crystal engineering : the design of organic solids

  1989cited by this paper

• Multi-to-uni modal knowledge transfer pre-training for molecular representation learning.

  2026cites this paper
• Multicomponent Cocrystals of 4-Chloro-3-sulfamoylbenzoic Acid with Carboxamides and Pyridine N -Oxides

  2025cites this paper
• Combining crystal engineering and surface engineering to estimate the structure -functions relationship of Tafamidis solid state forms with the aid of machine learning.

  2025cites this paper
• Pharmaceutical Organic Salts of Isoniazid, Nicotinic Acid, and Their Isomers: Structure, Aqueous Solubility, and Biological Studies

  2025cites this paper
• Advanced Drug Delivery Strategies to Overcome Solubility and Permeability Challenges: Driving Biopharmaceutical Advancements Toward Commercial Success

  2025influential citation
• Interpreting Lattice Water Incorporation in the Enhancement of Solubility and Membrane Permeability of Trimethoprim Molecular Salts

  2025cites this paper
• Bifunctional competitive antigen enhanced DLS Immunosensor for the ultrasensitive detection of furosemide in slimming products.

  2025cites this paper
• A COMPREHENSIVE REVIEW ON MULTI-DRUG COCRYSTALS

  2025cites this paper
• Elucidating the Mechanistic Shortcomings of Acetazolamide Cocrystals in Harnessing the Anticipated Solubility and Permeability Advantages

  2025cites this paper
• Revolutionizing sepsis therapy: Machine learning-driven co-crystallization reveals emodin's therapeutic potential

  2025cites this paper
• Innovative Strategies in Generic Drug Development: The Role of Polymorph, Amorphous, Pseudopolymorph, and Cocrystal Solid Forms

  2025cites this paper
• Resolving Salt-Cocrystal Conundrum in Multicomponent Crystals by Using X-Ray Quantum Crystallography

  2025cites this paper
• Asiatic acid cyclodextrin inclusion micro-cocrystal for insoluble drug delivery and acute lung injury therapy enhancement

  2024cites this paper
• Spring and parachute approach for piroxicam dissolution; its phenomenological model on the thermodynamics of irreversible processes.

  2024cites this paper
• Directed self-assembly with salicylic acid provides new crystalline complexes for fluoroquinolone antimicrobials to improve drug properties and synergies: theoretical and experimental integration research

  2024cites this paper
• Formulation and optimization of olanzapine-carboxylic acid cocrystals orodispersible tablets: In-vitro/ In-vivo study

  2024cites this paper
• Tetramethylpyrazine Cocrystals with Cinnamic Acid and Its Derivatives: Crystal Structures, Theoretical Computations, and Sublimation Behavior Studies

  2024cites this paper
• Cocrystal formulation design of 4-Aminosalicylic acid and isoniazid via spray-drying based on a ternary phase diagram toward simultaneous pulmonary delivery

  2024cites this paper
• Solid-Liquid Equilibrium Behavior and Data Correlation of Furosemide in 12 Pure Solvents from 283.15 to 323.15 K

  2024cites this paper
• Enhancing the Bioavailability of a Novel Enrofloxacin Salt by Inhibiting Precipitation via a Crystallization Inhibitor

  2024cites this paper
• Ethylenediamine Salt Enhances the Solubility and Dissolution of Flurbiprofen

  2024cites this paper
• Maleic Acid as a Co-Former for Pharmaceutically Active GABA Derivatives: Mechanochemistry or Solvent Crystallization?

  2023cites this paper
• The New Gatifloxacin‐p‐Coumaric Acid Cocrystalline Form for Enhanced In Vitro Pharmaceutical Properties While Improving Oral Bioavailability and Antibacterial Activity

  2023cites this paper
• Molecular complexes of drug combinations: a review of cocrystals, salts, coamorphous systems and amorphous solid dispersions.

  2023cites this paper
• Novel Pharmaceutical Cocrystal of Voxelotor, a Hemoglobin Oxygen Affinity Modulator: Synthesis, Crystal Structure, and Physicochemical Properties

  2023cites this paper
• Mechanisms of Drug Solubility Enhancement Induced by β-Lactoglobulin-Based Amorphous Solid Dispersions.

  2023cites this paper
• First Cocrystallization of Gatifloxacin with Nutraceuticals Displays the Ameliorated In Vitro/Vivo Biopharmaceutical Property and Increased Antibacterial Activity

  2023cites this paper
• DoE implementation for Telmisartan and hydrochlorothiazide drug-drug cocrystal synthesis to enhance physicochemical and pharmacokinetic properties

  2023cites this paper
• A method for improving the properties of famotidine

  2023cites this paper
• Cocrystals by Design: A Rational Coformer Selection Approach for Tackling the API Problems

  2023cites this paper
• Diffusion and Flux Improvement of Drugs through Complexation.

  2023cites this paper
• Ultrabright red-emitted aggregation-induced luminescence microspheres-based lateral flow immunoassay for furosemide detection in slimming products

  2023cites this paper
• Cocrystals of Nitrofurantoin: How Coformers Can Modify Its Solubility and Permeability Across Intestinal Cell Monolayers

  2022cites this paper
• An outlook on permeability escalation through cocrystallization for developing pharmaceuticals with improved biopharmaceutical properties

  2022cites this paper
• Comparative study of the cocrystals with layered/cavity structure in regulating in vitro pharmaceutical properties of diuretic acetazolamide

  2022cites this paper
• Heterosynthons, Solid Form Design and Enhanced Drug Bioavailability.

  2022cites this paper
• Lipid-Mediated Cocrystallization for Pharmaceutical Compounds

  2022cites this paper
• Computational Study of Furosemide-Piperazine (FS – PZ) and 2,3,5,6-tetramethylpyrazine (FS-TP) Co-Crystals

  2022cites this paper
• Crystal Engineering of Pharmaceutical Cocrystals in the Discovery and Development of Improved Drugs.

  2022cites this paper
• The First Cocrystallization of Milrinone with Nutraceuticals: The Adjusting Effects of Hydrophilicity/Hydrophobicity in Cavities on the In Vitro/In Vivo Properties of the Cocrystals

  2022cites this paper
• Furosemide/Non-Steroidal Anti-Inflammatory Drug–Drug Pharmaceutical Solids: Novel Opportunities in Drug Formulation

  2021cites this paper
• Salt solvates of quinolones and oxicams: Theoretical computation, structural characterization and dissolution studies

  2021cites this paper
• Synthetic Approaches to Halogen Bonded Ternary Cocrystals.

  2021cites this paper
• Cocrystallization of Amantadine Hydrochloride with Resveratrol: The First Drug–Nutraceutical Cocrystal Displaying Synergistic Antiviral Activity

  2021cites this paper
• Tuning Diffusion Permeability of an Anti-Retroviral Drug, Emtricitabine, via Multicomponent Crystallizations

  2021cites this paper
• Salt or/and cocrystal? The case of the antidepressant drug venlafaxine

  2021cites this paper
• Cocrystals Based on 4,4’-bipyridine: Influence of Crystal Packing on Melting Point

  2021cites this paper
• Crystal structure of five solid forms from isonicotinamide and carboxylic acids assembled by classical hydrogen bonds and other noncovalent interactions

  2021cites this paper
• Co-crystals formation specified from binary phase diagram studies; their thermochemical, spectroscopic and optical properties

  2021cites this paper
• A cocrystal for effectively reducing the hepatotoxicity of ethionamide

  2021cites this paper
• Novel Formulations of the Antiviral Drug Favipiravir: Improving Permeability and Tabletability

  2021cites this paper
• Study on the solubilization of telmisartan by forming cocrystals with aromatic carboxylic acids

  2021cites this paper
• Lateral Flow Immunochromatography Assay for Detection of Furosemide in Slimming Health Foods

  2021cites this paper
• A Piezoelectric Ionic Cocrystal of Glycine and Sulfamic Acid

  2021cites this paper
• Salts, solvates and hydrates of the multi-kinase inhibitor drug pazopanib with hydroxybenzoic acids

  2021cites this paper
• Multicomponent crystals of clotrimazole: a combined theoretical and experimental study

  2021cites this paper
• Effect of Surfactants and Polymers on the Dissolution Behavior of Supersaturable Tecovirimat-4-Hydroxybenzoic Acid Cocrystals

  2021cites this paper
• Isostructural cocrystals of metaxalone with improved dissolution characteristics

  2021cites this paper
• Raman Spectroscopic Study of Cinnamyl-1 Diphenylmethyl-4 Piperazine (Cinnarizine) at High Pressure

  2021cites this paper
• Sustained-Release Dual-Drug Ternary Salt Cocrystal of Piperazine Ferulate with Pyrazinamide: Synthesis, Structure, and Hirshfeld Surface Analysis

  2020cites this paper
• A new cocrystal of isoniazid-quercetin with hepatoprotective effect: The design, structure, and in vitro/in vivo performance evaluation.

  2020cites this paper
• New Salt and Cocrystal of Mequitazine: Impact of Coformer Flexibility and Hydrogen Bond Donors on Polymorphism

  2020cites this paper
• Drug-drug cocrystals: Opportunities and challenges

  2020cites this paper
• Solubility and Permeability Improvement of Allopurinol by Cocrystallization

  2020cites this paper
• Formation of the First Non-Isostructural Cocrystal of Apremilast Explained

  2020cites this paper
• The preparation and thermodynamic study of azelaic acid polymorphs in solution

  2020cites this paper
• Drug-Drug Binary Solids of Nitrofurantoin and Trimethoprim: Crystal Engineering and Pharmaceutical Properties.

  2020cites this paper
• Use of Spray Flash Evaporation (SFE) technology to improve dissolution of poorly soluble drugs: case study on furosemide nanocrystals.

  2020cites this paper
• Enhancing the solubility and permeability of the diuretic drug furosemide via multicomponent crystal forms.

  2020cites this paper
• Cocrystallization: cutting edge tool for physicochemical modulation of active pharmaceutical ingredients.

  2020cites this paper
• Pharmaceutical salts/cocrystals of enoxacin with dicarboxylic acids: Enhancing in vitro antibacterial activity of enoxacin by improving the solubility and permeability.

  2020cites this paper
• Furosemide Adducts with Hexamethylenetetramine, Amantadine, and Isoniazid: A Structural Case That Demonstrates the Effect of Carboxylic Acid Dimer and Sulfonic Acid Dimer on the Solubility

  2020cites this paper
• Progress on cocrystallization of poorly soluble NME's in the last decade

  2020cites this paper
• Cocrystallization with syringic acid presents a new opportunity for effectively reducing the hepatotoxicity of isoniazid

  2020cites this paper
• Effect of different cellulose polymers on the crystal growth of celecoxib polymorphs

  2020cites this paper
• Novel Pharmaceutical Cocrystals and Salts of Bumetanide

  2020cites this paper
• The first zwitterionic cocrystal of indomethacin with amino acid showing optimized physicochemical properties as well as accelerated absorption and slowed elimination in vivo

  2020cites this paper
• Pharmaceutical Cocrystals: Molecules, Crystals, Formulations, Medicines

  2019cites this paper
• Acid-ammonium heterodimer and N(ammonium)-H...N(pyridine) synthon preference in three salts of nicotinic acid with (1R,2R)-1,2-diphenylethylenediamine.

  2019cites this paper
• Facile Tuning of the Photoluminescence and Dissolution Properties of Phloretin through Cocrystallization

  2019cites this paper
• Enhancing the Pharmaceutical Properties of Pirfenidone by Mechanochemical Cocrystallization

  2019cites this paper
• Better in solubility enhancement : salt or cocrystal?

  2019cites this paper
• Tetrahydroberberine pharmaceutical salts/cocrystals with dicarboxylic acids: Charge-assisted hydrogen bond recognitions and solubility regulation

  2019cites this paper
• Hydrogen Bonding Assembled 3D Supramolecular Structures Formed by 5-Amino-2,4,6-triiodoisophthalic Acid and N-Heterocyclic Aromatic Ligands

  2019cites this paper
• Supramolecular synthon hierarchy in sulfonamide cocrystals with syn-amides and N-oxides

  2019cites this paper
• Simultaneously enhancing the in vitro/in vivo performances of acetazolamide using proline as a zwitterionic coformer for cocrystallization

  2019cites this paper
• Simultaneously Improving the Physicochemical Properties, Dissolution Performance, and Bioavailability of Apigenin and Daidzein by Co-Crystallization With Theophylline.

  2019cites this paper
• Furosemide:Triethanolamine Salt as a Strategy To Improve the Biopharmaceutical Properties and Photostability of the Drug

  2019cites this paper
• The comparative study of cocrystal/salt in simultaneously improving solubility and permeability of acetazolamide

  2019cites this paper
• Mechanistic Study on Complexation-Induced Spring and Hover Dissolution Behavior of Ibuprofen-Nicotinamide Cocrystal

  2018cites this paper
• Two-Component Pharmaceutical Cocrystals Regulated by Supramolecular Synthons Comprising Primary N···H···O Interactions

  2018cites this paper
• Triamterene–furosemide salt: structural aspects and physicochemical evaluation

  2018cites this paper
• Cocrystal of nutraceutical sinapic acid with Active Pharmaceutical Ingredients ethenzamide and 2-chloro-4-Nitrobenzoic acid: Equilibrium solubility and stability study

  2018cites this paper
• Bioinspired co‐crystals of Imatinib providing enhanced kinetic solubility

  2018cites this paper
• Protective Effects of Quercetin against Pyrazinamide Induced Hepatotoxicity via a Cocrystallization Strategy of Complementary Advantages

  2018cites this paper
• Expanding the Application and Formulation Space of Amorphous Solid Dispersions with KinetiSol®: a Review

  2018cites this paper
• The relevance of co‐amorphous formulations to develop supersaturated dosage forms: In‐vitro, and ex‐vivo investigation of Ritonavir‐Lopinavir co‐amorphous materials

  2018cites this paper
• Recent advances in improving oral drug bioavailability by cocrystals

  2018cites this paper
• ATP Induced Modulation in π–π Stacking Interactions in Pyrene Based Zinc Complexes: Chemosensor Study and Quantitative Investigation of Apyrase Activity

  2018cites this paper
• Innovation with Non‐Covalent Derivatization

  2018cites this paper